Category : Search result: enlicitide

New Oral Cholesterol Pill Shows 58% LDL Reduction

Breakthrough oral PCSK9 inhibitor enlicitide reduces LDL cholesterol by 58.2% in global trial, offering injection-free alternative for heart disease prevention.